Three Blood Biomarkers Predict Higher Risk of Heart Attack, Stroke in Women

Translate to Spanish or other 102 languages!

Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
- Advertisement -
  • Cardiovascular disease is the leading cause of death in women globally. 
  • There have historically been disparities in diagnosing cardiovascular disease in women as they may have no or different symptoms than men. 
  • Researchers from Brigham and Women’s Hospital found measuring three different biological blood markers can better predict a woman’s risk of having a major cardiovascular event over the next 30 years compared to measuring only one biomarker.

Cardiovascular disease is the leading cause of death in women around the globe, while stroke is the third most commonTrusted Source.

Follow the link to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/3-blood-biomarkers-predict-higher-risk-of-heart-attack-stroke-in-women?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -